AN2 Therapeutics, Inc. (ANTX) Tops Q4 EPS by 2c

AN2 Therapeutics, Inc. (NASDAQ: ANTX) reported Q4 EPS of ($0.25), $0.02 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on AN2 Therapeutics, Inc. (ANTX) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• Elastic N.V. (ESTC) Tops Q1 EPS by 12c, Beats on Revenue; offers FY27 Guidance
• Ulta Beauty (ULTA) Tops Q2 EPS by 38c, Offers Outlook